PATHIOS THERAPEUTICS
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
PATHIOS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pathiostherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+44 1865 292 039
Total Funding:
13.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Alentis Therapeutics
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Asylia Therapeutics
Asylia Therapeutics is a biotech company focused on novel immune-modulating therapies for autoimmune, cancer, and infectious diseases.
Centauri Therapeutics
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Chronos Therapeutics
Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Elixirgen Therapeutics
Elixirgen Therapeutics is a biotechnology company focused on the development of therapies for genetic diseases and vaccines.
Ermium Therapeutics
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
Grey Wolf Therapeutics
Small molecules to increase tumor detection by the immune system
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
NRG Therapeutics
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
Orega Biotech
Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer.
Phosphate Therapeutics
Phosphate Therapeutics is focused on the development of mineral-derived hospital pharmaceuticals.
ProQR Therapeutics
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
SciRhom
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
VectorY
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Pathios Therapeutics
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Series A - Pathios Therapeutics
Official Site Inspections
http://www.pathiostherapeutics.com
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pathios Therapeutics"
Home - Pathios Therapeutics
Jul 9, 2019 Pathios is a clinical-stage oncology and immunology company that targets the acid-sensing GPCR, GPR65, as a unique and genetically-validated immune cell receptor with the potential to revolutionise oncology treatment …See details»
About Us - Pathios Therapeutics
Pathios Therapeutics is a drug discovery and development company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs.See details»
Our Team - Pathios Therapeutics
Pathios brings together a team of experienced scientific leaders and drug discovery professionals to deliver on the therapeutic promise of targeting the innate immune system in cancer.See details»
Pathios Therapeutics Company Profile 2024: Valuation, Funding ...
Operator of a drug discovery company intended to identify and develop small-molecule G protein-coupled receptor (GPR65) inhibitors for applications in immuno-oncology.See details»
Pathios Therapeutics - Crunchbase Company Profile & Funding
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer. Pathios Therapeutics raised $25 million in the first close of …See details»
Pathios Therapeutics - LinkedIn
Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases.See details»
Pathios Therapeutics: Contact Details and Business Profile
Pathiostherapeutics.com; pathios.com; María Martín Project Manager at Pathios Therapeutics Oxford, GB View. View Similar People. Related Companies PsiOxus. 98 $16m Novartis UK. …See details»
Company Spotlight: Pathios Therapeutics | Milton Park
Jul 27, 2022 To find out more about the work that Pathios Therapeutics do, visit their website at pathiostherapeutics.com. Share this article. Related news News. News / Business. Timelapse …See details»
Pathios Therapeutics - Products, Competitors, Financials, …
Pathios Therapeutics provides biotechnology solutions. It focuses on oncology and immunology, targeting the GPR65 receptor to transform cancer treatment.See details»
Pathios Therapeutics - Craft
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.See details»
Pathios Therapeutics - Company Profile & Staff Directory
Pathios Therapeutics is an early-stage drug discovery company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based …See details»
Pathios Therapeutics Raises $25M in First Close of Series B …
Apr 18, 2024 Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced that the company has …See details»
Pathios Therapeutics Appoints Paul G. Higham as Chief Executive …
Jul 9, 2024 Founding CEO, Stuart Hughes, Ph.D., to Transition to Chief Scientific Officer and Focus Efforts on Advancing Company's First-of-its-Kind GPR65 Inhibition Approach to …See details»
Pathios Therapeutics Presents Preclinical In Vivo Proof of Concept …
OXFORD, United Kingdom, July 7, 2021 /PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), an innovative biotech company focused on the development of first-in-class …See details»
Pathios Therapeutics Raises $25M in First Close of Series B …
Apr 18, 2024 Pathios Therapeutics Limited (“Pathios”), a biotech company focused on the development of first-in-class therapies for cancer, today announced that the company has …See details»
Pathios Therapeutics Raises $25M in First Close of Series B …
Apr 18, 2024 /PRNewswire/ -- Pathios Therapeutics Limited ("Pathios"), a biotech company focused on the development of first-in-class therapies for cancer, today announced...See details»
Pathios Therapeutics & Sygnature Sign Strategic Partnership
Feb 6, 2019 Pathios Therapeutics and Sygnature Discovery sign strategic partnership to discover novel GPR65 modulators for the treatment of autoimmune disease and cancer.See details»
Latest News & Updates - Pathios Therapeutics
Cookie Duration Description-settings-1, wp-settings-time-1: 1 year: WordPress uses this cookie to customize your view of admin interface, and possibly also the main site interface.See details»
Pathios Therapeutics Unveils PTT-4256, a Highly Potent and …
Apr 17, 2023 Pathios Therapeutics Unveils PTT-4256, a Highly Potent and Selective Inhibitor of GPR65, in Presentation at American Association for Cancer Research (AACR) Annual …See details»
Science - Pathios Therapeutics
Pathios is exploiting a proprietary understanding of the human genetics and functional immunology of GPR65 to bring about a revolutionary new approach to treating cancerSee details»